Clindamycin Hydrochloride
- Product NDC
- 70934-281
- 11-digit product format
- 709340281
- Labeler code
- 70934
- Product ID
- 70934-281_d44a9ea9-4e0d-ec6c-e053-2a95a90a2bd5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clindamycin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA063083
- Marketing category
- ANDA
- Marketing start
- 2019-07-26
- Marketing end
- 0000-00-00
- Substance
- CLINDAMYCIN HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS],Neuromuscular Blockade [PE]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-281-30 | 70934028130 | 30 CAPSULE in 1 BOTTLE, PLASTIC (70934-281-30) | 30 capsule | 2019-08-22 | 0000-00-00 | No | No | Current |
| 70934-281-40 | 70934028140 | 40 CAPSULE in 1 BOTTLE, PLASTIC (70934-281-40) | 40 capsule | 2019-07-26 | 0000-00-00 | No | No | Current |